首页> 外文会议>Society for Biomaterials annual meeting and exposition >20/20 OptimEyes: Drug Delivery Solutions to Improve Ocular Health
【24h】

20/20 OptimEyes: Drug Delivery Solutions to Improve Ocular Health

机译:20/20 OptimEyes:改善眼部健康的药物输送解决方案

获取原文

摘要

Technology: Dry eye disease (DED) is a multifactoral, chronic and progressive disorder affecting over 5 million people in the USA alone. Epidemiological studies have shown that the impact of DED on quality of life is equivalent to dialysis or severe angina. The symptoms include scratchiness, inflammation, grittiness, foreign body sensation and compromised vision. There is no cure for DED, and limited FDA approved treatment options currently exist, requiring multiple drops per day that are painful to administer and can take months to work.
机译:技术:干眼病(DED)是一种多因素,慢性和进行性疾病,仅在美国就影响了超过500万人。流行病学研究表明,DED对生活质量的影响等同于透析或严重心绞痛。症状包括scratch痒,发炎,沙哑,异物感和视力受损。 DED尚无治愈方法,目前存在有限的FDA批准的治疗选择,每天需要多次滴剂,给患者带来痛苦,并且可能需要几个月的时间才能工作。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号